Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06834802

3D Analysis of Soft Tissue Healing After Immediate Implant Placement Using PRF Vs HAM

3D Analysis of Soft Tissue Healing After Immediate Implant Placement in Molar Sites Using PRF Vs HAM: A Randomized Controlled Clinical Study in Molar Sites Using PRF Vs HAM: A Randomized Controlled Clinical Study

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
36 (estimated)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Statement of the problem: Soft tissue healing following immediate implant placement is one of the major factors that affect implant restoration, function \& success. Aim: The aim of this study is to compare the effect of using HAM (Human amniotic membrane) and platelet rich fibrin (PRF) in soft tissue healing with immediate implant placement in the molar region.

Detailed description

Aim: The aim of this study is to compare the effect of using HAM (Human amniotic membrane) and platelet rich fibrin (PRF) in soft tissue healing with immediate implant placement in the molar region. Materials and Methods: This parallel arm, randomized controlled clinical trial will involve systemically free patients with remaining roots or badly decayed teeth in molar sites region requiring implant placement. They will be randomly allocated to three equal groups. Group A (test group, n=12) will receive immediate implants (grafting with PRF), group B (test group, n=12) will receive immediate implants (grafting with HAM) and group c (test group, n=12) will receive immediate implants (no grafting). After implant placement, soft tissue healing (1ry outcome) and postoperative pain (2nd outcome) will be assessed. The parameters will be assessed at baseline, every day for the first week, day after day second week, once in third and fourth week. Postoperative pain and swelling will be recorded daily by the patient for the 1st two weeks post surgically. Postoperative medication will be prescribed to the patient and postoperative instructions will be explained in detail. Follow-up will be performed to assess the parameters and to ensure performing proper oral hygiene. Data collected will be tabulated and statistically analyzed.

Conditions

Interventions

TypeNameDescription
PROCEDUREPRFPRF membrane will be used for soft tissue grafting around implant
PROCEDUREHuman amniotic membraneHuman amniotic membrane will be used for soft tissue grafting around implan
PROCEDURENo graftingNo soft tissue grafting around implant

Timeline

Start date
2025-01-07
Primary completion
2025-08-01
Completion
2025-09-01
First posted
2025-02-19
Last updated
2025-02-19

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06834802. Inclusion in this directory is not an endorsement.